Transcriptional silencing of EphB6 receptor tyrosine kinase in invasive breast carcinoma cells and detection of methylated promoter by methylation specific PCR

Biochemical and Biophysical Research Communications

Volumn 340, Issue 1, 2006, Pages 268-276

  Fox, Brian P ^a   Kandpal, Raj P ^a  

^a FORDHAM UNIVERSITY   (United States)

Author keywords

5 Aza 2 deoxycytidine; Breast cancer; Breast carcinoma cell lines; EphB6; Methylation specific PCR; Sodium bisulfite sequencing; Transcriptional silencing

Indexed keywords

5 AZA 2' DEOXYCYTIDINE; EPHRIN RECEPTOR B6; PROTEIN P300; PROTEIN TYROSINE KINASE; TRANSCRIPTION FACTOR SP1;

ARTICLE; BINDING SITE; BREAST CANCER; CANCER INVASION; CARCINOMA CELL; CARCINOMA IN SITU; CONTROLLED STUDY; CORRELATION ANALYSIS; CPG ISLAND; DEMETHYLATION; DNA METHYLATION; GENE AMPLIFICATION; GENE EXPRESSION; GENE SEQUENCE; GENETIC TRANSCRIPTION; HUMAN; HUMAN CELL; HUMAN TISSUE; NUCLEOTIDE SEQUENCE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROGNOSIS; PROMOTER REGION; REPORTER GENE; STATISTICAL SIGNIFICANCE; TRANSCRIPTION INITIATION; TRANSCRIPTION REGULATION;

BREAST NEOPLASMS; CELL LINE, TUMOR; DNA METHYLATION; GENE SILENCING; HUMANS; NEOPLASM INVASIVENESS; POLYMERASE CHAIN REACTION; PROMOTER REGIONS (GENETICS); RECEPTOR, EPHB6; TRANSCRIPTION, GENETIC; TUMOR MARKERS, BIOLOGICAL;

EID: 29244470819     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2005.11.174     Document Type: Article

References (47)

1. A. Lal, A.E. Lash, S.F. Altschul, V. Velculescu, L. Zhang, R.E. McLendon, M.A. Marra, C. Prange, P.J. Morin, K. Polyak, N. Papadopoulous, B. Vogelstein, K.W. Kinzler, R.L. Strausberg, and G.J. Riggins A public database for gene expression in human cancers Cancer Res. 59 1999 5403 5407
2. P.J. Moran, and A.T. Weeraratna Wnt signaling in human cancer Cancer Treat. Res. 115 2003 169 187
3. K.A. Waite, and C. Eng From developmental disorder to heritable cancer, its all in the BMP/TGF-beta family Nat. Rev. Genet. 10 2003 763 773
4. T. Bogenrieder, and M. Herlyn Axis of evil: molecular mechanisms of cancer metastasis Oncogene 22 2003 6524 6536
5. S. Adhikary, and M. Eilers Transcriptional regulation and transformation by Myc protein Nat. Rev. Mol. Cell Biol. 8 2005 635 645
6. K. Gaston, and P.S. Jajaraman Transcriptional repression in eukaryotes: repressors and repression mechanisms Cell. Mol. Life Sci. 60 2003 721 741
7. R. Weinmann The basic RNA polymerase II transcriptional machinery Gene Expr. 2 1992 81 91
8. A.M. Melnick, K. Adelson, and J.D. Licht The theoretical basis of transcriptional therapy of cancer: can it be put into practice? J. Clin. Oncol. 17 2005 3957 3970
9. J. Gilbert, S.D. Gore, J.G. Herman, and M.A. Carducci The clinical application of targeting cancer through histone acetylation and hypomethylation Clin. Cancer Res. 14 2004 4589 4596
10. P.M. Das, and R. Singal DNA methylation and cancer J. Clin. Oncol. 22 2004 4632 4642
11. L. Pusztai, F.W. Symmans, and G.N. Hortobagyi Development of pharmacogenomic markers to select preoperative chemotherapy for breast cancer Breast Cancer 2 2005 73 85
12. J.P. Himanen, and P.B. Nikolov Molecules in focus. Eph receptors and ephrins Int. J. Biochem. Cell Biol. 35 2003 130 134
13. N. Nakamoto Molecules in focus. Eph receptors and ephrins Int. J. Biochem. Cell Biol. 32 2000 7 12
14. H. Surawska, P.C. Ma, and R. Salgia The role of ephrins and Eph receptors in cancer Cytokine Growth Factor Rev. 6 2004 419 433
15. K. Kullander, and R. Klein Mechanisms and functions of Eph and ephrin signaling Nat. Cell Biol. 3 2002 475 486
16. J. Holmberg, D.L. Clarke, and J. Frisen Regulation of repulsion versus adhesion by different splice forms of an Eph receptor Nature 408 2000 203 206
17. Q. Xu, and D.G. Wilkinson Eph-related receptors and their ligands: mediators of contact dependent cell interactions J. Mol. Med. 75 1997 576 586
18. R.H. Adams Vascular patterning by Eph receptor tyrosine kinases and ephrins Semin. Cell Dev. Biol. 13 2002 55 60
19. U. Dresher The Eph family in the patterning of neural development Curr. Biol. 7 1997 R799 R807
20. A.C. Andres, H.H. Reid, G. Zürcher, R.J. Blaschke, D. Albrecht, and A. Ziemiecki Expression of two novel eph related receptor protein tyrosine kinases in mammary gland development and carcinogenesis Oncogene 9 1994 1461 1467
21. D.J. Easty, and D.C. Bennett Protein tyrosine kinases in malignant melanoma Melanoma Res. 10 2000 401 411
22. J. Walker-Daniels, K. Coffman, M. Azimi, J.S. Rhim, D.G. Bostwick, P. Snyder, B.J. Kerns, D.J. Waters, and M.S. Kinch Overexpression of the EphA2 tyrosine kinase in prostate cancer Prostate 41 1999 275 280
23. H. Kataoka, H. Igarashi, M. Kanamori, M. Ihara, J.-D. Wang, Y.-J. Wang, Z.-Y. Li, T. Shimamura, T. Kobayashi, K. Maruyama, T. Nakamura, H. Arai, M. Kajimura, H. Hanai, M. Tanaka, and H. Sugimura Coorelation of EphA2 overexpression with high microvessel count in human primary colorectal cancer Cancer Sci. 95 2004 136 141
24. S.A. Stephenson, S. Slomka, E.L. Douglas, P.J. Hewett, and J.E. Hardingham Receptor protein tyrosine kinase EphB4 is upregulated in colon cancer BMC Mol. Biol. 2 2001 15
25. T. Miyazaki, H. Kato, M. Fukuchi, M. Nakajima, and H. Kuwano EphA2 overexpression correlates with poor prognosis in esophageal squamous cell carcinoma Int. J. Cancer 103 2003 657 663
26. M.S. Kinch, M.-B. Moore, and D.J. Harpole Jr. Predictive value of the EphA2 receptor tyrosine kinase in lung cancer recurrence and survival Clin. Cancer Res. 63 2003 613 618
27. M. Lu, K.D. Miller, Y. Gokemen-Polar, M.-H. Jeng, and M.S. Kinch EphA2 overexpression decreases estrogen dependence and tamoxifen sensitivity Cancer Res. 63 2003 3425 3429
28. W. Liu, S.A. Ahmad, Y.D. Jung, N. Reinmuth, F. Fan, C.D. Bucana, and L.M. Ellis Coexpression of ephrin-Bs and their receptors in colon carcinoma Cancer 94 2002 934 939
29. X.X. Tang, A.E. Evans, H. Zhao, A. Cnaan, W. London, S.L. Cohn, G.M. Brodeur, and N. Ikegaki High level expression of EPHB6, EFNB2, and EFNB3 is associated with low tumor stage and high TrkA expression in human neroblastomas Clin. Cancer Res. 5 1999 1491 1496
30. X.X. Tang, H. Zhao, M.E. Robinson, B. Cohen, A. Cnaan, W. London, S.L. Cohn, N.-K.V. Cheung, G.M. Brodeur, A.E. Evans, and N. Ikegaki Implications of EPHB6, EFNB2, and EFNB3 expressions in human neuroblastoma Proc. Natl. Acad. Sci. USA 97 2000 10936 10941
31. C. Müller-Tidow, S. Diederichs, E. Bulk, T. Pohle, B. Steffen, J. Schwäble, S. Plewka, M. Thomas, R. Metzger, P.M. Schneider, C.H. Brandts, W.E. Berdel, and H. Serve Identification of metastasis-associated receptor tyrosine kinases in non-small cell lung cancer Cancer Res. 65 2005 1778 1782
32. C. Hafner, F. Bataille, S. Meyer, B. Becker, A. Roesch, M. Landthaler, and T. Vogt Loss of EphB6 expression in metastatic melanoma Int. J. Oncol. 6 2003 1553 1559
33. B.P. Fox, and R.P. Kandpal Invasiveness of breast carcinoma cells and transcript profile: Eph receptors and ephrin ligands as molecular markers of potential diagnostic and prognostic application Biochem. Biophys. Res. Commun. 318 2004 882 892
34. J. Wang, H. Kataoka, M. Suzuki, N. Sato, R. Nakamura, H. Tao, K. Maruyama, J. Isogaki, S. Kanaoka, M. Ihara, M. Tanaka, M. Kanamori, T. Nakamura, K. Shinmura, and H. Sugimura Downregulation of EphA7 by hypermethylation in colorectal cancer Oncogene 24 2005 5637 5647
35. X.X. Tang, M.E. Robinson, J.S. Riceberg, D.Y. Kim, B. Kung, T.B. Titus, S. Hayashi, A.W. Flake, D. Carpentieri, and N. Ikegaki Favorable neuroblastoma genes and molecular therapeutics of nueroblastoma Clin. Cancer Res. 10 2004 5837 5844
36. O. Galm, and J.G. Herman Methylation-specific polymerase chain reaction Methods Mol. Med. 113 2005 279 291
37. M.J. Fackler, M. McVeigh, J. Mehrotra, M.A. Blum, J. Lange, A. Lapides, E. Garrett, P. Argani, and S. Sukumar Quantitative multiplex methylation-specific PCR assay for the detection of promoter hypermethylation in multiple genes in breast cancer Cancer Res. 64 2004 4442 4452
38. H. Koike, D. Ichikawa, H. Ikoma, N. Tani, D. Ikoma, E. Otsuji, K. Okamoto, Y. Ueda, K. Kitamura, and H. Yamagishi Comparison of serum aberrant methylation and conventional tumor markers in gastric cancer patients Hepatogastroenterology 52 2005 1293 1296
39. J.C. Lai, Y.W. Cheng, H.L. Chiou, M.F. Wu, C.Y. Chen, and H. Lee Gender differences in estrogen receptor alpha promoter hypermethylation and its prognostic value in non-small cell lung cancer Int. J. Cancer 2005 epub ahead of print
40. N. Umetani, T. Mori, K. Koyanagi, M. Shinozaki, J. Kim, A.E. Giuliano, and D.S. Hoon Aberrant hypermethylation of ID4 gene promoter region increases risk of lymph node metastasis in T1 breast cancer Oncogene 24 2005 4721 4727
41. T. Chiba, O. Yokosuka, K. Fukai, Y. Hirasawa, M. Tada, R. Mikata, F. Imazeki, H. Taniguchi, A. Iwama, M. Miyazaki, T. Ochiai, and H. Saisho Identification and investigation of methylated genes in hepatoma Eur. J. Cancer 41 2005 1185 1194
42. B.N. Kim, H. Yamamoto, K. Ikeda, B. Damdinsuren, Y. Sugita, C.Y. Ngan, Y. Fujie, M. Ogawa, T. Hata, M. Ikeda, M. Ohue, N. Sekimoto, T. Monden, N. Matsuura, and M. Monden Methylation and expression of p16INK4 tumor suppressor gene in primary colorectal cancer tissues Int. J. Oncol. 26 2005 1217 1226
43. J.T. Chen, Y.W. Cheng, M.C. Chou, T. Sen-Lin, W.W. Lai, W.L. Ho, and H. Lee The correlation between aberrant connexin 43 mRNA expression induced by promoter methylation and nodal micrometastasis in non-small cell lung cancer Clin. Cancer Res. 11 2003 4200 4204
44. H. Maier, J. Colbert, D. Fitzsimmons, D.R. Clark, and J. Hagman Activation of the early B-cell- specific mb-1 (Ig-alpha) gene by Pax-5 is dependent on an unmethylated Ets binding site Mol. Cell. Biol. 6 2003 1946 1960
45. Y. Guo, P. Pakneshan, J. Gladu, A. Slack, M. Szyf, and S.A. Rabbani Regulation of DNA methylation in human breast cancer. Effect on the urokinase-type plasminogen activator gene production and tumor invasion J. Biol. Chem. 44 2002 41571 41579
46. S. Honorio, A. Agathanggelou, M. Schuermann, W. Pankow, O. Viacava, E.R. Maher, and F. Latif Detection of RASSF1A aberrant promoter hypermethylation in sputum from chronic smokers and ductal carcinoma in situ from breast cancer patients Oncogene 22 2005 147 150
47. C. Jeronimo, I. Costra, M.C. Martins, P. Monteiro, S. Lisboa, C. Palmeira, R. Henrique, M.R. Teixeira, and C. Lopes Detection of gene promoter hypermethylation in fine needle washings from breast lesions Clin. Cancer Res. 9 2003 3413 3417